
    
      1. Test the hypothesis that nebivolol treatment decreases PAI-1 antigen and activity and
           improves fibrinolytic balance compared to metoprolol treatment in individuals with
           metabolic syndrome.

        2. Test the hypothesis that nebivolol treatment improves insulin sensitivity compared to
           metoprolol treatment in individuals with metabolic syndrome.
    
  